TARBP2 and neoplasm: Notably, overexpressed or downregulated TARBP2 was found in various cancers [128–130], and the assumption of improvement in tumor angiogenesis and metastasis was verified through dysregulating miRNAs in lung, breast, and liver cancer cell lines [131].